Guardant Health
GH
#1169
Rank
S$24.96 B
Marketcap
S$184.54
Share price
-0.52%
Change (1 day)
47.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report